Guardian Pharmacy Service (GRDN) Stock Price, Quote, News & History | Benzinga

Guardian Pharmacy Services Inc (GRDN) Stock Price, Quote, News & History

GRDNNYSE

Trade with Public

Trade with Public

$41.47

-2.36-5.38%

At close: Aug 10, 5:00 PM EST

$43.96

2.496%

After Hours: 8:58 AM EST

Earnings: Q2 2026 Earnings were released on Thu Aug 6th, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 4 days ago

Click to view the webcast

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$43.45

Close

$41.47

Volume / Avg.

454.69K / 413.67K

Day Range

$40.99 - $44.13

52 Wk Range

19.30 - 47.02

Market Cap

$2.78B

P/E Ratio

42.14

Dividend Yield

-

Exchange

NYSE

RSI

52

Short Interest

7.52%

Days to Cover

7.13

Recent Guardian Pharmacy Services, Inc. News

This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed outlook on top names. See analyst rating changes, including upgrades/downgrades/initiations, on Benzinga.

Avi Kapoor

Stock Market Today: S&P 500, Dow Jones Futures Slip As Jobless Claims Fall To 205,000— Micron, FedEx, Constellation Energy In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs, the lede, and the headline were updated in the story.) U.S. stock futures fell on Thursday following Wednesday’s declines. Futures of the major benchmark indices were lower. Initial jobless claims fell to 205,000 for the week ending March 14, underscoring a tight labor market.

Rishabh Mishra

Alibaba Posts Downbeat Earnings, Joins Guardian Pharmacy, Micron And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Stock futures slightly lower, Alibaba falls after downbeat earnings, other stocks decline in pre-market trading.

Avi Kapoor

Why Five Below Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Five Below Inc (FIVE) shares rose 7.2% in pre-market trading after reporting better-than-expected Q4 results and issuing strong FY26 EPS guidance. Other gainers include LBGJ, ASNS, SVRN, SUNE, MDAI, SER, VACH, SBDS, and VG. Losers include WNW, RVPH, RYDE, and AZI.

Avi Kapoor

Micron, Accenture And 3 Stocks To Watch Heading Into Thursday

US stock futures mixed on Thursday, with focus on Accenture, Micron, Alibaba's earnings. Guardian Pharmacy announces public offering.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

98.86M

Investing Cash Flow (TTM)

-22.73M

Financing Cash Flow (TTM)

-5.13M

Free Cash Flow (TTM)

79.79M

Capital Expenditure (TTM)

-19.07M

Net Change in Cash (TTM)

70.99M

Analyst Trends and Forecast

3

Mar

2

Apr

1

May

2

Jun

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.72B

PE Ratio (TTM)

42.14

PE Ratio (FWD)

35.59

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.91

PB Ratio (TTM)

11.30

Earnings Yield % (TTM)

2.37%

Earnings Yield % (FWD)

2.81%

EV / EBITDA (TTM)

22.72

Price / EBITDA (TTM)

23.28

Price / Free Cash Flow (TTM)

34.97

Book Value / Share

$3.88

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$4.86M

Total Cash

$89.81M

Debt to Equity

0.14

Issuance of Debt (TTM)

-$4.86M

Repayment of Debt (TTM)

-$4.86M

Key Statistics

Open

$43.45

Close

$41.47

Volume / Avg.

454.69K / 413.67K

Day Range

$40.99 - $44.13

52 Wk Range

19.30 - 47.02

Market Cap

$2.78B

P/E Ratio

42.14

Dividend Yield

-

Exchange

NYSE

RSI

52

Short Interest

7.52%

Days to Cover

7.13

About

Sector

Health Care

Industry

Health Care Providers & Services

Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical ou...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Guardian Pharmacy Service (GRDN) stock?

A

You can purchase shares of Guardian Pharmacy Service (NYSE:GRDN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Guardian Pharmacy Service (GRDN) competitors?

A

Other companies in Guardian Pharmacy Service’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Labcorp Holdings Inc (NYSE:LH) and Guardant Health Inc (NASDAQ:GH).

Q

What is the forecast, or price target, for Guardian Pharmacy Service (GRDN) stock?

A

Guardian Pharmacy Service has a consensus price target of $40.67.

Q

What is the current price for Guardian Pharmacy Service (GRDN)?

A

The stock price for Guardian Pharmacy Service (NYSE: GRDN) is $43.96 last updated August 10, 2026 at 8:58 AM EDT.

Q

Does Guardian Pharmacy Service (GRDN) pay a dividend?

A

There are no upcoming dividends for Guardian Pharmacy Service.

Q

When is Guardian Pharmacy Service (NYSE:GRDN) reporting earnings?

A

Guardian Pharmacy Service does not have any upcoming earnings scheduled.

Q

Is Guardian Pharmacy Service (GRDN) going to split?

A

There is no upcoming split for Guardian Pharmacy Service.

Q

What sector and industry does Guardian Pharmacy Service (GRDN) operate in?

A

Guardian Pharmacy Service is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.